Polymorphisms in the dopamine transporter gene (SLC6A3/DAT1) and alcohol dependence in humans: a systematic review

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

Bibliography

• 1  Grant BF, Dawson DA, Stinson FS et al.: The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991–1992 and 2001–2002. Drug Alcohol Depen.74,223–234 (2004).
  MedlineGoogle Scholar
• 2  Goldman D, Oroszi G, Ducci F: The genetics of addictions: uncovering the genes. Nat. Rev. Genet.6,521–532 (2005).▪ Clear review on the genetics of addiction.
  Medline CASGoogle Scholar
• 3  Kendler KS, Prescott CA, Neale MC, Pederson NL: Temperance board registration for alcohol abuse in a national sample of Swedish male twins, born 1902 to 1949. Arch. Gen. Psych.54,178–184 (1997).
  Medline CASGoogle Scholar
• 4  McGue M: The behavioral genetics of alcoholism. Curr. Dir. Psychol. Sci.8,109–115 (1999).
  Google Scholar
• 5  Pagan JL, Rose RJ, Viken RJ et al.: Genetic and environmental influences on stages of alcohol use across adolescence and into young adulthood. Behav. Gen.36,483–497 (2006).
  MedlineGoogle Scholar
• 6  Prescott CA, Kendler KS: Genetic and environmental contributions to alcohol abuse and dependence in a population based sample of male twins. Am. J. Psychiat.156,34–30 (1999).
  Medline CASGoogle Scholar
• 7  Berridge KC, Robinson TE: What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience. Brain Res. Rev.28,309–369 (1998).
  Medline CASGoogle Scholar
• 8  Wise RA, Rompre PP: Brain dopamine and reward. Ann. Rev. Psychol.40,191–225 (1989).
  Medline CASGoogle Scholar
• 9  Persico AM, Vandenbergh DJ, Smith SS, Uhl GR: Dopamine transporter gene polymorphisms are not associated with polysubstance abuse. Biol. Psychiat.34,265–267 (1993).
  Medline CASGoogle Scholar
• 10  Uhl G: Neurotransmitter transporter (plus): A promising new gene family. Trends Neurosci.15,265–268 (1992).
  MedlineGoogle Scholar
• 11  Giros B, El Mestikawy S, Godinot N et al.: Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol. Pharmacol.42,383–390 (1992).
  Medline CASGoogle Scholar
• 12  Drgon T, Lin Z, Wang G-J et al.: Common human 5´ dopamine transporter ( SLC6A3) haplotypes yield varying expression levels in vivo. Cell. Mol. Neurobiol.26,875–889 (2006).
  Medline CASGoogle Scholar
• 13  Laine TPJ, Ahonen A, Torniainen P et al.: Dopamine transporters increase in human brain after alcohol withdrawal. Mol. Psychiatr.4,189–191 (1999).
  Medline CASGoogle Scholar
• 14  Mash DC, Staley JK, Doepel FM et al.: Altered dopamine transporter densities in alcohol-preferring vervet monkeys. Neuroreport7,457–462 (1996).
  Medline CASGoogle Scholar
• 15  Repo E, Kuikka JT, Bergstrom KA et al.: Dopamine transporter and D2-density in late-onset alcoholism. Psychopharmacology147,314–318 (1999).
  Medline CASGoogle Scholar
• 16  Tiihonen J, Kuikka J, Bergström K et al.: Altered striatal dopamine re-uptake site densities in habitually violent and non-violent alcoholics. Nat. Med.1,654–657 (1995).
  Medline CASGoogle Scholar
• 17  Heinz A, Ragan P, Jones DW et al.: Reduced central serotonin transporters in alcoholism. Am. J. Psychiat.155,1544–1549 (1998).
  Medline CASGoogle Scholar
• 18  Volkow ND, Wang G, Fowler JS et al.: Decreases in dopamine receptors, not in dopamine transporters in alcoholics. Alcohol. Clin. Exp. Res.20,1594–1588 (1996).
  Medline CASGoogle Scholar
• 19  Bannon MJ, Michelhaugh SK, Wang J, Sacchetti P: The human dopamine transporter gene: gene organization, transcriptional regulation, and potential involvement in neuropsychiatric disorders. Eur. Neuropsychopharm.11,449–455 (2001).
  Medline CASGoogle Scholar
• 20  Grünhage F, Schulz TG, Müller DJ et al.: Systematic screening for DNA sequence variation in the coding region on the human dopamine transporter gene ( DAT1). Mol. Psychiatr.5,275–282 (2000).
  Medline CASGoogle Scholar
• 21  Kawarai T, Kawakami H, Yamamura Y, Nakamura S: Structure and organization of the gene encoding human dopamine transporter. Gene195,11–18 (1997).
  Medline CASGoogle Scholar
• 22  Ueno S, Nakamura M, Mikami M et al.: Identification of a novel polymorphism of the human dopamine transporter ( DAT1) gene and the significant association with alcoholism. Mol. Psychiatr.4,552–557 (1999).
  Medline CASGoogle Scholar
• 23  Vandenbergh DJ, Thompson MD, Cook EH et al.: Human dopamine transporter gene: Coding region conservation among normal, Tourette’s disorder, alcohol dependence and attention-deficit hyperactivity disorder. Mol. Psychiatr.5,283–292 (2000).
  Medline CASGoogle Scholar
• 24  Vandenbergh DJ, Persico AM, Hawkins AL et al.: Human dopamine transporter gene ( DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics14,1104–1106 (1992).
  Medline CASGoogle Scholar
• 25  Wernicke C, Smolka M, Gallinat J et al.: Evidence for the importance of the human dopamine transporter gene for withdrawal symptomatology of alcoholics in a German population. Neurosci. Lett.333,45–48 (2002).
  Medline CASGoogle Scholar
• 26  Choi IG, Kee BS, Son HG et al.: Genetic polymorphisms of alcohol and aldehydogenase, dopamine and serotonin transporters in familial and non-familial alcoholism. Eur. Neuropsychopharm.16,123–128 (2006).
  Medline CASGoogle Scholar
• 27  Kang AM, Palmatier MA, Kidd KK: Global variation of a 40-bp VNTR in the 32 untranslated region of the dopamine transporter gene ( SLC6A3). Biol. Psychiat.46,151–160 (1999).
  Medline CASGoogle Scholar
• 28  Mitchell RJ, Howlett S, Earl L et al.: Distribution of the 3´ VNTR polymorphism in the human dopamine transporter gene in world populations. Hum. Biol.72,295–304 (2000).
  Medline CASGoogle Scholar
• 29  Santovito A, Cervella P, Selvaggi A et al.: DAT1 VNTR polymorphisms in a European and an African population: Identification of a new allele. Hum. Biol.80,191–198 (2008).
  MedlineGoogle Scholar
• 30  Conne B, Stutz A, Vassalli JD: The 3´ untranslated region of messenger RNA: a molecular ‘hotspot’ for pathology? Nat. Med.6,637–641 (2000).
  Medline CASGoogle Scholar
• 31  Greenwood TA, Alexander M, Keck PE et al.: Segmental linkage disequilibrium within the dopamine transporter gene. Mol. Psychiatr.7,165–173 (2002).
  Medline CASGoogle Scholar
• 32  Savelieva KV, Caudle WM, Findlay GS, Caron MG, Miller GW: Decreased ethanol preference and consumption in dopamine transporter female knock-out mice. Alcohol. Clin. Exp. Res.26,758–764 (2002).
  Medline CASGoogle Scholar
• 33  Hall FS, Sora I, Uhl GR: Sex-dependent modulation of ethanol consumption in vesicular monoamine transporter 2 ( VMAT2) and dopamine transporter ( DAT) knockout mice. Neuropsychopharmacol.28,620–628 (2003).
  MedlineGoogle Scholar
• 34  Fuke S, Suo S, Takahashi N, Koike H, Sasagawa N, Ishiura S: The VNTR polymorphism of the human dopamine transporter ( DAT1) gene affects gene expression. Pharmacogenomics J.1,152–156 (2001).
  Medline CASGoogle Scholar
• 35  Heinz A, Goldman D, Jones DW et al.: Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacol.22,133–139 (2000).
  Medline CASGoogle Scholar
• 36  Inoue-Murayama M, Adachi S, Mishima N et al.: Variation of variable number of tandem repeat sequences in the 3´-untranslated region of primate dopamine transporter genes that affects reporter gene expression. Neurosci. Lett.334,206–210 (2002).
  Medline CASGoogle Scholar
• 37  Michelhaugh SK, Fiskerstrand C, Lovejoy A, Bannon MJ, Quinn PJ: The dopamine transporter gene ( SLC6A3) variable number of tandem repeats domain enhances transcription in dopamine neurons. J. Neurochem.79,1033–1038 (2001).
  Medline CASGoogle Scholar
• 38  Mill J, Asherson P, Browes C, D’Souza U, Craig I: Expression of the dopamine transporter gene is regulated by the 3´ UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR. Am. J. Med. Genet.114,975–979 (2002).
  MedlineGoogle Scholar
• 39  Miller GM, Madras BK: Polymorphisms in the 3´-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. Mol. Psychiatr.7,44–55 (2002).
  Medline CASGoogle Scholar
• 40  VanNess SH, Owens MJ, Kilts CD: The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density. BMC Genet.6,55 (2005).
  MedlineGoogle Scholar
• 41  Foley PF, Loh EW, Innes DJ et al.: Association studies of neurotransmitter gene polymorphisms in alcohol Caucasians. Ann. NY Acad. Sci.1025,39–46 (2004).
  Medline CASGoogle Scholar
• 42  Chen WJ, Chen CH, Huang J et al.: Genetic polymorphisms of the promoter region of dopamine D2 receptor and dopamine transporter genes and alcoholism among four aboriginal groups and Han Chinese in Taiwan. Psychiatr. Genet.11,187–195 (2001).
  Medline CASGoogle Scholar
• 43  Le Strat Y, Ramoz N, Pickering P et al.: The 3´ part of the dopamine transporter gene DAT1/ SLC6A3 is associated with withdrawal seizures in patients with alcohol dependence. Alcohol. Clin. Exp. Res.32,27–35 (2008).
  Medline CASGoogle Scholar
• 44  Muramatsu T, Higuchi S: Dopamine transporter gene polymorphism and alcoholism. Biochem. Bioph. Res. Co.211,28–32 (1995).
  Medline CASGoogle Scholar
• 45  Parsian A, Zhang ZH: Human dopamine transporter gene polymorphism (VNTR) and alcoholism. Am. J. Med. Genet.74,480–482 (1997).
  Medline CASGoogle Scholar
• 46  Sander T, Harms H, Podschus J et al.: Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium. Biol. Psychiat.41,299–304 (1997).
  Medline CASGoogle Scholar
• 47  Samochowiec J, Kucharska-Mazur J, Grzywacz A et al.: Family-based and case–control study of DRD2, DAT, 5HTT, COMT genes polymorphisms in alcohol dependence. Neurosci. Lett.410,1–5 (2006).
  Medline CASGoogle Scholar
• 48  Dobashi I, Inada T, Hadano K: Alcoholism and gene polymorphisms related to central dopaminergic transmission in the Japanese population. Psychiatr. Genet.7,87–91 (1997).
  Medline CASGoogle Scholar
• 49  Bau CHD, Almeida S, Costa FT et al.: DRD4 and DAT1 as modifying genes in alcoholism: interaction with novelty seeking on level of alcohol consumption (scientific correspondence). Mol. Psychiatr.6,7–9 (2001).
  Medline CASGoogle Scholar
• 50  Köhnke MD, Batra A, Kolb W et al.: Association of the dopamine transporter gene with alcoholism. Alcohol Alcoholism40,339–342 (2005).
  MedlineGoogle Scholar
• 51  Franke P, Schwab SG, Knapp M et al.: DAT1 gene polymorphism in alcoholism: a family-based association study. Biol. Psychiat.45,652–654 (1999).
  Medline CASGoogle Scholar
• 52  Gorwood P, Limosin F, Batel P et al.: The A9 allele of the dopamine transporter gene is associated with delirium tremens and alcohol-withdrawal seizure. Biol. Psychiat.53,85–92 (2003).
  Medline CASGoogle Scholar
• 53  Limosin F, Loze JY, Boni C et al.: The A9 allele of the dopamine transporter gene increases the risk of visual hallucinations during alcohol withdrawal in alcohol-dependent women. Neurosci. Lett.362,91–94 (2004).
  Medline CASGoogle Scholar
• 54  Schmidt LG, Harms H, Kuhn S, Rommelspacher H, Sander T: Modification of alcohol withdrawal by the A₉ allele of the dopamine transporter gene. Am. J. Psychiat.155,474–478 (1998).
  Medline CASGoogle Scholar
• 55  Yoshida A, Huang IY, Ikawa M: Molecular abnormality of an inactive aldehyde dehydrogenase variant commonly found in Orientals. Proc. Natl Acad. Sci. USA81,258–261 (1984).
  Medline CASGoogle Scholar
• 56  Falk CT, Rubinstein P: Haplotype relative risks: An easy reliable way to construct a proper control sample for risk calculations. Ann. Hum. Genet.51,227–233 (1987).
  Medline CASGoogle Scholar
• 57  Szot P, Reigel CE, White SS, Veith RC: Alterations in mRNA expression of systems that regulate neurotransmitter synaptic content in seizure-naive genetically epilepsy-prone rat (GEPR): transporter proteins and rate-limiting synthesizing enzymes for norepinephrine, dopamine and serotonin. Brain Res. Mol. Brain Res.43,233–245 (1996).
  Medline CASGoogle Scholar
• 58  Sander T, Berlin W, Ostapowicz A et al.: Variation of the genes encoding the human glutamate EAAT2, serotonin and dompaine transporters and susceptibility to idiopathic generalized epilepsy. Epilepsy Res.41,75–81 (2001).
  Google Scholar
• 59  van der Zwaluw CS, Engels RCME: Gene–environment interactions and alcohol use and dependence: current status and future challenges. Addiction (2008) (In press).
  Google Scholar
• 60  Flint J, Munafò MR: Forum: interactions between gene and environment. Curr. Opin. Psychiatr.21,315–317 (2008).
  MedlineGoogle Scholar
• 61  Yang B, Chan RCK, Jing J et al.: A meta-analysis of asociation studies between the 10-repeat allele of a VNTR polymorphism in the 3´-UTR of dopamine transporter gene and attention deficit disorder. Am. J. Med. Genet.144B,541–550 (2007).▪▪ Thorough meta-analysis on the association between DAT1 and attention deficit–hyperactivity disorder.
  Medline CASGoogle Scholar
• 62  Johann M, Bobbe G, Putzhammer A, Wodarz N: Comorbidity of alcohol dependence with attention-deficit hyperactivity disorder: Differences in phenotype with increased severity of the substance disorder, but not in genotype (serotonin transporter and 5-hydroxytryptamine-2c receptor). Alcohol. Clin. Exp. Res.27,1527–1534 (2003).
  Medline CASGoogle Scholar
• 63  van der Zwaluw CS, van den Wildenberg E, Wiers RW et al.: Polymorphisms in the µ-opioid receptor gene ( OPRM1) and the implications for alcohol dependence in humans. Pharmacogenomics8,1427–1436 (2007).
  CASGoogle Scholar
• 64  Konishi T, Calvillo M, Leng AS, Lin KM, Wan YJY: Polymorphisms of the dopamine D2 receptor, serotonin transporter, and GABA_A receptor β3 subunit genes and alcoholism in Mexican–Americans. Alcohol32,45–52 (2004).
  Medline CASGoogle Scholar
• 65  Cordell HJ: Epistasis, what it means, what it doesn’t mean, and statistical methods to detect it in humans. Hum. Mol. Gen.11,2463–2468 (2002).
  Medline CASGoogle Scholar
• 66  Poelen EA, Engels RC, van der Vorst H, Scholte RH, Vermulst AA: Best friends and alcohol consumption in adolescence: a within-family analysis. Drug Alcohol Depend.88,163–173 (2007).
  MedlineGoogle Scholar
• 67  van der Vorst H, Engels RCME, Dekovic M, Meeus W: Alcohol-specific rules, personality, and adolescents’ alcohol use: a longitudinal person–environment study. Addiction102,1064–1075 (2007).
  MedlineGoogle Scholar
• 68  Windle M, Davies PT: Depression and heavy alcohol use among adolescents: concurrent and prospective relations. Dev. Psychopathol.11,823–844 (1999).
  Medline CASGoogle Scholar
• 69  Nilsson KW, Sjoberg RL, Wargelius H et al.: The monoamine oxidase A ( MAO-A) gene, family function and maltreatment as predictors of destructive behaviour during male adolescent alcohol consumption. Addiction102,389–398 (2007).
  MedlineGoogle Scholar
• 70  Nilsson KW, Sjöberg RL, Damberg M et al.: Role of serotonin transporter gene and family function in adolescent alcohol consumption. Alcohol. Clin. Exp. Res.29,564–570 (2005).
  Medline CASGoogle Scholar
• 71  Rutter M: Nature, nurture, and development: From evangelism through science toward policy and practice. Child Dev.73,1–21 (1997).
  Google Scholar
• 72  Madrid GA, MacMurray J, Lee JW, Anderson BA, Comings DE: Stress as a mediating factor in the association between the DRD2 taq1 polymorphism and alcoholism. Alcohol23,117–122 (2001).▪ One of the first studies to examine gene–environment interactions in alcoholism.
  Medline CASGoogle Scholar
• 73  Caspi A, McClay J, Moffit TE et al.: Role of genotype in the cycle of violence in maltreated children. Science297,851–854 (2002).▪▪ Neoclassical example of the implication of a gene–environment interaction in research.
  Medline CASGoogle Scholar
• 74  Nilsson K, Sjoberg R, Damberg M et al.: Role of monoamine oxidase A genotype and psychosocial factors in male adolescent criminal activity. Biol. Psychiat.59,121–127 (2005).
  MedlineGoogle Scholar
• 75  van der Zwaluw CS, Engels RC, Vermulst AA: Interaction between dopamine D2 receptor genotype and parental rule-setting in adolescent alcohol use: evidence for a gene-parenting interaction. Mol. Psychiatr. (2009) (Epub ahead of print).
  MedlineGoogle Scholar
• 76  Uher R: Forum: The case for gene–environment interactions in psychiatry. Curr. Opin. Psychiatr.21,318–321 (2008).
  MedlineGoogle Scholar
• 77  Guerrini I, Cook CH, Kest W et al.: Genetic linkage analyses supports the presence of two susceptibility loci for alcoholism and heavy drinking on chromosome 1p22.1–11.2 and 1q21.3–24.2. BMC Genetics6 (2005).
  MedlineGoogle Scholar
• 78  Prescott CA, Sullivan PF, Kuo P-H et al.: Genomewide linkage study in the Irish affected sib pair study of alcohol dependence: evidence for a susceptibility region for symptoms of alcohol dependence on chromosome 4. Mol. Psychiatr.11,603–611 (2006).
  Medline CASGoogle Scholar
• 79  Gottesman II, Gould TD: The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiat.160,636–645 (2003).
  MedlineGoogle Scholar
• 80  Dick DM, Jones K, Saccone N et al.: Endophenotypes successfully lead to gene identification: results from the collaborative study on the genetics of alcoholism. Behav. Genet.36,112–126 (2006).
  MedlineGoogle Scholar
• 81  Rietschel M: Environment is important. Curr. Opin. Psychiatr.21,323–324 (2008).
  MedlineGoogle Scholar
• 82  Chakravarti A, Little P: Nature, nurture and human disease. Nature421,412–414 (2003).▪ Inspiring paper on the need of gene–environment studies.
  MedlineGoogle Scholar
• 83  Buckland PR: Will we ever find the genes for addiction? Addiction103,1768–1776 (2008).
  MedlineGoogle Scholar
• 84  Purcell S, Cherny SS, Sham PC: Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics19,149–150 (2003).
  Medline CASGoogle Scholar